Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Fang

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Urology|October 18, 2021
Stereotactic body radiation therapy with simultaneous integrated boost for prostate cancer: does MRI-targeted biopsy alter the boost field?Andrew M Fang, Zachary R Burns, Alexander P Nocera, et al.
Current Treatment Options in Oncology|January 11, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
Journal of Robotic Surgery|March 1, 2020
Perioperative outcomes of laparoscopic, robotic, and open approaches to pheochromocytomaAndrew M Fang, Jennifer Rosen, Ava Saidian, et al.
Current Treatment Options in Oncology|April 20, 2024
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
The Journal of Urology|August 24, 2021
Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible LesionsHiten D Patel, Elizabeth L Koehne, Steven M Shea, et al.
BJU International|June 23, 2022
A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculatorsHiten D Patel, Elizabeth L Koehne, Steven M Shea, et al.
JAMA Network Open|March 7, 2024
Comparison of Magnetic Resonance Imaging-Based Risk Calculators to Predict Prostate Cancer RiskHiten D Patel, Sebastiaan Remmers, Jeffrey L Ellis, et al.
BJU International|November 5, 2025
Prostate zonal impact of 5α-reductase inhibitors on multiparametric MRI characteristics and detection of prostate cancerArighno Das, Marcelo Bigarella, Krista Brackman, et al.
Prostate Cancer and Prostatic Diseases|September 17, 2024
Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancerAndrew M Fang, Brian F Chapin, Charles W Shi, et al.
Urologic Oncology|May 21, 2026
Impact of intraoperative intravenous heparin bolus on clinical outcomes during radical nephrectomy and IVC tumor thrombectomy in renal cell carcinoma with level I-IV IVC thrombus: A multi-institutional studyAhmet Murat Aydin, Alireza Dehghanmanshadi, Vaneeza Mukhtar, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Urology|October 18, 2021
Stereotactic body radiation therapy with simultaneous integrated boost for prostate cancer: does MRI-targeted biopsy alter the boost field?Andrew M Fang, Zachary R Burns, Alexander P Nocera, et al.
Current Treatment Options in Oncology|January 11, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
Journal of Robotic Surgery|March 1, 2020
Perioperative outcomes of laparoscopic, robotic, and open approaches to pheochromocytomaAndrew M Fang, Jennifer Rosen, Ava Saidian, et al.
Current Treatment Options in Oncology|April 20, 2024
Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate CancerAndrew M Fang, Jamaal Jackson, Justin R Gregg, et al.
The Journal of Urology|August 24, 2021
Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible LesionsHiten D Patel, Elizabeth L Koehne, Steven M Shea, et al.
BJU International|June 23, 2022
A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculatorsHiten D Patel, Elizabeth L Koehne, Steven M Shea, et al.
JAMA Network Open|March 7, 2024
Comparison of Magnetic Resonance Imaging-Based Risk Calculators to Predict Prostate Cancer RiskHiten D Patel, Sebastiaan Remmers, Jeffrey L Ellis, et al.
BJU International|November 5, 2025
Prostate zonal impact of 5α-reductase inhibitors on multiparametric MRI characteristics and detection of prostate cancerArighno Das, Marcelo Bigarella, Krista Brackman, et al.
Prostate Cancer and Prostatic Diseases|September 17, 2024
Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancerAndrew M Fang, Brian F Chapin, Charles W Shi, et al.
Urologic Oncology|May 21, 2026
Impact of intraoperative intravenous heparin bolus on clinical outcomes during radical nephrectomy and IVC tumor thrombectomy in renal cell carcinoma with level I-IV IVC thrombus: A multi-institutional studyAhmet Murat Aydin, Alireza Dehghanmanshadi, Vaneeza Mukhtar, et al.
Pageof 4